JPRN-UMIN000019351招募中未知
Efficacy and Safety of Granulocytapheresis against severe alcoholic hepatitis - Granulocytapheresis against severe alcoholic hepatitis
Division of Gastroenterology & Hepatology, Department of Internal Medicine, School of Medicine, Keio University0 个研究点目标入组 50 人开始时间: 2015年10月14日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •the patients whose granulocyte count are below 2000 the patients who complicated with severe infection, severe heart disease, uncontrolled cancer, and end-stage liver cirrhosis the patients who are pregnant
研究者
相似试验
暂停
不适用
Granulocytapheresis against severe alcoholic hepatitissevere alcoholic hepatitisalcoholic hepatitisJPRN-jRCTs032180221akamoto Nobuhiro30
尚未招募
1 期
Study on safety and efficacy of granulocyte transfusion mobilized with G-CSF in related donorSevere neutropenic patients following alloHSCT or chemotherapyJPRN-UMIN000014777Kansai Medical University10
进行中（未招募）
1 期
Testing granulocyte-colony stimulating factor (GCSF) in patients with Friedreich AtaxiaFriedreich AtaxiaEUCTR2017-003084-34-GBniversity of Bristol7
已完成
4 期
Safety assessment of Granulocyte Colony Stimulating Factor:ior LeukoCIM in oncohematologic patients.Phase IV study.eutropenia secondary to Chemotherapy and/or Radiotherapy in oncohematologic patients .RPCEC00000083Center of Molecular Immunology(CIM)
进行中（未招募）
1 期
Efficacy of immunoglobulins in pediatric early-onset corticosteroid nephrotic syndromeChildhood-Onset steroid-dependent nephrotic syndromeMedDRA version: 20.1Level: PTClassification code 10029164Term: Nephrotic syndromeSystem Organ Class: 10038359 - Renal and urinary disordersEUCTR2017-000826-36-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)90